| Melbourne Terrace Rehabilitation Center | |
| 251 Florida Ave, Melbourne, Florida 32901 | |
| (321) 725-3990 | |
| Name | Melbourne Terrace Rehabilitation Center |
|---|---|
| Location | 251 Florida Ave, Melbourne, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 170 |
| Occupancy Rate | 93.18% |
| Medicare ID (CCN) | 105635 |
| Legal Business Name | Melbourne Terrace Rcc, Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1376530956 |
| Organization Name | MELBOURNE TERRACE RCC, LLC |
| Doing Business As | MELBOURNE TERRACE REHABILITATION CENTER |
| Address | 251 E Florida Ave, Melbourne, FL 32901 |
| Phone Number | 321-725-3990 |
News Archive
Should corporations have the right to get out of obeying federal law and refuse services and deny health care coverage to some people because of the corporate owners' religious beliefs? That's the question the U.S. Supreme Court is weighing this month – and the answer could affect millions of Americans' everyday lives (Cecile Richards and Chad Griffin, 3/18).
A new device may enable breast cancer screening and cancer detection in populations where mammography is not widely available or successful, including women in developing countries, and those under the age of 40.
Drs. Andrew Goldstein, Owen Witte, and Tanya Stoyanova and their colleagues from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have found that prostate cancer can develop in one type of stem cell, then evolve to be maintained by a stem cell that looks very different, making prostate cancer stem cells a "moving target" for treatments. The breakthrough discovery connects directly to the development of future therapeutics that target cancer and was published online ahead of print in the Proceedings of the National Academy of Sciences.
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013 today.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Should corporations have the right to get out of obeying federal law and refuse services and deny health care coverage to some people because of the corporate owners' religious beliefs? That's the question the U.S. Supreme Court is weighing this month – and the answer could affect millions of Americans' everyday lives (Cecile Richards and Chad Griffin, 3/18).
A new device may enable breast cancer screening and cancer detection in populations where mammography is not widely available or successful, including women in developing countries, and those under the age of 40.
Drs. Andrew Goldstein, Owen Witte, and Tanya Stoyanova and their colleagues from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have found that prostate cancer can develop in one type of stem cell, then evolve to be maintained by a stem cell that looks very different, making prostate cancer stem cells a "moving target" for treatments. The breakthrough discovery connects directly to the development of future therapeutics that target cancer and was published online ahead of print in the Proceedings of the National Academy of Sciences.
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013 today.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.19 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 1.61 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 52.42 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.65 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.11 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 4.44 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.26 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.69 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.51 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.02 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.63 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 14.41 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.93 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.57 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.1 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 76.75 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.93 | 82.93 |
News Archive
Should corporations have the right to get out of obeying federal law and refuse services and deny health care coverage to some people because of the corporate owners' religious beliefs? That's the question the U.S. Supreme Court is weighing this month – and the answer could affect millions of Americans' everyday lives (Cecile Richards and Chad Griffin, 3/18).
A new device may enable breast cancer screening and cancer detection in populations where mammography is not widely available or successful, including women in developing countries, and those under the age of 40.
Drs. Andrew Goldstein, Owen Witte, and Tanya Stoyanova and their colleagues from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have found that prostate cancer can develop in one type of stem cell, then evolve to be maintained by a stem cell that looks very different, making prostate cancer stem cells a "moving target" for treatments. The breakthrough discovery connects directly to the development of future therapeutics that target cancer and was published online ahead of print in the Proceedings of the National Academy of Sciences.
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013 today.
› Verified 8 days ago
Wave Crest Health And Rehabilitation Center Location: 1415 S Hickory St, Melbourne, Florida 32901 Phone: (321) 723-1321 | |
Life Care Center Of Melbourne Location: 606 E Sheridan Rd, Melbourne, Florida 32901 Phone: (321) 727-0984 | |
Melbourne Terrace Rehabilitation Center Location: 251 Florida Ave, Melbourne, Florida 32901 Phone: (321) 725-3990 | |
Avante At Melbourne Inc Location: 1420 South Oak Street, Melbourne, Florida 32901 Phone: (321) 723-3215 | |
Consulate Health Care Of Melbourne Location: 3033 Sarno Rd, Melbourne, Florida 32934 Phone: (321) 255-9200 | |
Atlantic Shores Nursing And Rehab Center Location: 4251 Stack Blvd, Melbourne, Florida 32901 Phone: (321) 953-2219 |